{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T00:11:15Z","timestamp":1721952675982},"reference-count":31,"publisher":"The Endocrine Society","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Context:<\/jats:title>\n                  <jats:p>Patients with pulmonary arterial hypertension (PAH) who develop hyperthyroidism are at risk for acute cardiopulmonary decompensation and death.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Cases and Setting:<\/jats:title>\n                  <jats:p>We present a series of eight idiopathic PAH\/heritable PAH pediatric patients who developed hyperthyroidism between 1999 and 2011. Institutional Review Board approval was obtained; informed consent was waived due to the retrospective nature of the series. All eight patients were receiving iv epoprostenol; five of the eight patients presented with acute cardiopulmonary decompensation in the setting of hyperthyroidism. In the remaining three patients, hyperthyroidism was detected during routine screening of thyroid function tests. The one patient who underwent emergency thyroidectomy was the only survivor of those who presented in cardiopulmonary decline.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Evidence Synthesis:<\/jats:title>\n                  <jats:p>Aggressive treatment of the hyperthyroid state, including emergency total thyroidectomy and escalation of targeted PAH therapy and \u03b2-blockade when warranted, may prove lifesaving in these patients. Prompt thyroidectomy or radioactive iodine ablation should be considered for clinically stable PAH patients with early and\/or mild hyperthyroidism to avoid potentially life-threatening cardiopulmonary decompensation.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions:<\/jats:title>\n                  <jats:p>Although the association between hyperthyroidism and PAH remains poorly understood, the potential impact of hyperthyroidism on the cardiopulmonary status of PAH patients must not be ignored. Hyperthyroidism must be identified early in this patient population to optimize intervention before acute decompensation. Thyroid function tests should be checked routinely in patients with PAH, particularly those on iv epoprostenol, and urgently in patients with acute decompensation or symptoms of hyperthyroidism.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/jc.2012-1109","type":"journal-article","created":{"date-parts":[[2012,5,29]],"date-time":"2012-05-29T21:55:15Z","timestamp":1338328515000},"page":"2217-2222","source":"Crossref","is-referenced-by-count":11,"title":["Pediatric Pulmonary Arterial Hypertension and Hyperthyroidism: A Potentially Fatal Combination"],"prefix":"10.1210","volume":"97","author":[{"given":"Christine M.","family":"Trapp","sequence":"first","affiliation":[{"name":"Divisions of Pediatric Endocrinology, Diabetes, and Metabolism (C.M.T., A.B.S., S.L., G.S.A., A.T.G.), New York, New York 10032"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert W.","family":"Elder","sequence":"additional","affiliation":[{"name":"Pediatric Cardiology (R.W.E., E.B.R.), Department of Pediatrics, Children's Hospital of New York Presbyterian, Columbia University College of Physicians and Surgeons, New York, New York 10032"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrienne T.","family":"Gerken","sequence":"additional","affiliation":[{"name":"Divisions of Pediatric Endocrinology, Diabetes, and Metabolism (C.M.T., A.B.S., S.L., G.S.A., A.T.G.), New York, New York 10032"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aviva B.","family":"Sopher","sequence":"additional","affiliation":[{"name":"Divisions of Pediatric Endocrinology, Diabetes, and Metabolism (C.M.T., A.B.S., S.L., G.S.A., A.T.G.), New York, New York 10032"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shulamit","family":"Lerner","sequence":"additional","affiliation":[{"name":"Divisions of Pediatric Endocrinology, Diabetes, and Metabolism (C.M.T., A.B.S., S.L., G.S.A., A.T.G.), New York, New York 10032"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaya S.","family":"Aranoff","sequence":"additional","affiliation":[{"name":"Divisions of Pediatric Endocrinology, Diabetes, and Metabolism (C.M.T., A.B.S., S.L., G.S.A., A.T.G.), New York, New York 10032"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erika B.","family":"Rosenzweig","sequence":"additional","affiliation":[{"name":"Pediatric Cardiology (R.W.E., E.B.R.), Department of Pediatrics, Children's Hospital of New York Presbyterian, Columbia University College of Physicians and Surgeons, New York, New York 10032"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","reference":[{"key":"2020071615365349400_B1","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1016\/j.jacc.2009.04.015","article-title":"Genetics and genomics of pulmonary arterial hypertension.","volume":"54","author":"Machado","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"2020071615365349400_B2","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1161\/01.CIR.0000138104.83366.E9","article-title":"Outcomes in children with idiopathic pulmonary arterial hypertension.","volume":"110","author":"Yung","year":"2004","journal-title":"Circulation"},{"key":"2020071615365349400_B3","article-title":"The role of inflammation and autoimmunity in the pathophysiology of pulmonary arterial hypertension","author":"Kherbeck","year":"2011","journal-title":"Clin Rev Allergy Immunol"},{"key":"2020071615365349400_B4","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1053\/rmed.2001.1260","article-title":"Hyperthyroidism and pulmonary hypertension.","volume":"96","author":"Marvisi","year":"2002","journal-title":"Respir Med"},{"key":"2020071615365349400_B5","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1111\/j.1440-1843.2008.01353.x","article-title":"Pulmonary hypertension responding to hyperthyroidism treatment.","volume":"13","author":"Hegazi","year":"2008","journal-title":"Respirology"},{"key":"2020071615365349400_B6","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1378\/chest.122.5.1668","article-title":"High prevalence of autoimmune thyroid disease in pulmonary arterial hypertension.","volume":"122","author":"Chu","year":"2002","journal-title":"Chest"},{"key":"2020071615365349400_B7","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1253\/circj.CJ-09-0369","article-title":"Autoimmune thyroid disease in children and adolescents with idiopathic pulmonary arterial hypertension.","volume":"74","author":"Satoh","year":"2010","journal-title":"Circ J"},{"key":"2020071615365349400_B8","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1378\/chest.119.6.1980","article-title":"Pulmonary arterial hypertension and thyroid disease.","volume":"119","author":"Ferris","year":"2001","journal-title":"Chest"},{"key":"2020071615365349400_B9","doi-asserted-by":"crossref","first-page":"116","DOI":"10.4158\/EP.15.2.116","article-title":"Effect of epoprostenol on the thyroid gland: enlargement and secretion of thyroid hormone.","volume":"15","author":"Chadha","year":"2009","journal-title":"Endocr Pract"},{"key":"2020071615365349400_B10","first-page":"133","article-title":"Epoprostenol and thyroid disease.","volume":"16","author":"del Castillo Palma","year":"2010","journal-title":"Endocr Pract"},{"key":"2020071615365349400_B11","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.jacc.2010.09.059","article-title":"Risk of potentially life-threatening thyroid dysfunction due to amiodarone in idiopathic pulmonary arterial hypertension patients.","volume":"57","author":"Soon","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"2020071615365349400_B12","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1161\/CIRCULATIONAHA.108.839274","article-title":"Tadalafil therapy for pulmonary arterial hypertension.","volume":"119","author":"Gali\u00e8","year":"2009","journal-title":"Circulation"},{"key":"2020071615365349400_B13","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/j.jacc.2009.04.012","article-title":"Updated clinical classification of pulmonary hypertension.","volume":"54","author":"Simonneau","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"2020071615365349400_B14","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.2169\/internalmedicine.47.1420","article-title":"Autoimmune hepatitis associated with pulmonary arterial hypertension.","volume":"47","author":"Kaneko","year":"2008","journal-title":"Intern Med"},{"key":"2020071615365349400_B15","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.ijcard.2006.05.053","article-title":"Pulmonary hypertension associated with autoimmune hemolytic anemia: a case report.","volume":"115","author":"Zhang","year":"2007","journal-title":"Int J Cardiol"},{"key":"2020071615365349400_B16","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1007\/s00246-010-9704-y","article-title":"Primary pulmonary arterial hypertension and autoimmune polyendocrine syndrome in a pediatric patient.","volume":"31","author":"Alghamdi","year":"2010","journal-title":"Pediatr Cardiol"},{"key":"2020071615365349400_B17","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1183\/09031936.06.00133505","article-title":"Autoimmune polyglandular syndrome and pulmonary arterial hypertension.","volume":"27","author":"Garc\u00eda-Hern\u00e1ndez","year":"2006","journal-title":"Eur Respir J"},{"key":"2020071615365349400_B18","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.jacc.2009.01.004","article-title":"ACCF\/AHA 2009 Expert consensus document on pulmonary hypertension.","volume":"53","author":"McLaughlin","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"2020071615365349400_B19","first-page":"3767","article-title":"Clinical review 99: the management of Graves' disease in children, with special emphasis on radioiodine treatment.","volume":"83","author":"Rivkees","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071615365349400_B20","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1159\/000320028","article-title":"Pediatric Graves' disease: controversies in management.","volume":"74","author":"Rivkees","year":"2010","journal-title":"Horm Res Paediatr"},{"key":"2020071615365349400_B21","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1136\/bjo.86.7.740","article-title":"Ophthalmopathy in childhood Graves' disease.","volume":"86","author":"Chan","year":"2002","journal-title":"Br J Ophthalmol"},{"key":"2020071615365349400_B22","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1001\/archinte.1988.00380030132023","article-title":"Graves' disease. Influence of age on clinical findings.","volume":"148","author":"Nordyke","year":"1988","journal-title":"Arch Intern Med"},{"key":"2020071615365349400_B23","doi-asserted-by":"crossref","first-page":"456","DOI":"10.4158\/EP.17.3.456","article-title":"Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists.","volume":"17","author":"Bahn","year":"2011","journal-title":"Endocr Pract"},{"key":"2020071615365349400_B24","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1001\/archinte.1989.00390030032006","article-title":"Sensitivity, specificity, and cost-effectiveness of the sensitive thyrotropin assay in the diagnosis of thyroid disease in ambulatory patients.","volume":"149","author":"de los Santos","year":"1989","journal-title":"Arch Intern Med"},{"key":"2020071615365349400_B25","first-page":"310","article-title":"Graves' disease in childhood: advances in management with antithyroid drug therapy.","volume":"71","author":"Kaguelidou","year":"2009","journal-title":"Horm Res"},{"key":"2020071615365349400_B26","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1210\/jc.2006-1239","article-title":"An optimal treatment for pediatric Graves' disease is radioiodine.","volume":"92","author":"Rivkees","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071615365349400_B27","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1172\/JCI106864","article-title":"Thyrotropin increases prostaglandin levels in isolated thyroid cells.","volume":"51","author":"Yu","year":"1972","journal-title":"J Clin Invest"},{"key":"2020071615365349400_B28","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1210\/endo-96-4-1018","article-title":"Effect of PGE1 and TSH on cAMP-dependent protein kinase activity in the thyroid.","volume":"96","author":"Spaulding","year":"1975","journal-title":"Endocrinology"},{"key":"2020071615365349400_B29","doi-asserted-by":"crossref","first-page":"618S","DOI":"10.1378\/chest.128.6_suppl.618S","article-title":"Bone morphogenetic protein receptor 2 mutations in adults and children with idiopathic pulmonary arterial hypertension: association with thyroid disease.","volume":"128","author":"Roberts","year":"2005","journal-title":"Chest"},{"key":"2020071615365349400_B30","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1210\/jcem.86.5.7473","article-title":"Thyroid storm in a child following radioactive iodine (RAI) therapy: a consequence of RAI versus withdrawal of antithyroid medication.","volume":"86","author":"Kadmon","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071615365349400_B31","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1210\/jc.2006-2135","article-title":"Comparison of methimazole and propylthiouracil in patients with hyperthyroidism caused by Graves' disease.","volume":"92","author":"Nakamura","year":"2007","journal-title":"J Clin Endocrinol Metab"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/97\/7\/2217\/10781873\/jcem2217.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/97\/7\/2217\/10781873\/jcem2217.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T02:48:34Z","timestamp":1594954114000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/97\/7\/2217\/2833828"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7,1]]},"references-count":31,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012,7,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2012-1109","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7,1]]}}}